购物车

全部删除
您的购物车当前为空

FGF-21 Protein, Human, Recombinant (CHO, His)

产品编号 TMPS-00031

FGF-21 Protein, Human, Recombinant (CHO, His) is expressed in CHO Cells. The accession number is Q9NSA1.

FGF-21 Protein, Human, Recombinant (CHO, His)

产品编号 TMPS-00031

FGF-21 Protein, Human, Recombinant (CHO, His) is expressed in CHO Cells. The accession number is Q9NSA1.

规格	价格	库存
10 μg	¥ 590	5日内发货
50 μg	¥ 1,570	现货
1 mg	待询	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

选择批次

资源下载

COA 重组蛋白用户指南

产品信息

生物活性	ED 50 < 0.3 μg/ml, measured in a bioassay using NIH-3T3 cells.
产品描述	FGF-21 Protein, Human, Recombinant (CHO, His) is expressed in CHO Cells. The accession number is Q9NSA1.
种属	Human
表达系统	CHO Cells
标签	His
蛋白编号	Q9NSA1
别名	fibroblast growth factor-21,FGFL,FGF21
蛋白构建	His29-Ser209
蛋白纯度	> 95% as determined by SDS-PAGE
分子量	23~25 kDa (Reducing conditions)
内毒素	< 0.2 EU/μg of protein as determined by the LAL method.
缓冲液	Lyophilized from a 0.2 μm filtered solution in PBS.
复溶方法	Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
存储	Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	FGF-21, also known as fibroblast growth factor-21 and FGFL, is a secreted growth factor belonging to theheparin-binding growth factor family. It is produced by hepatocytes in response to fatty acid stimulation. FGF-21 couples with its co-factor beta-Klotho to signal through FGFR1c and FGFR4. Signal transduction results in insulin-independent uptake of glucose by adipocytes. Clinical administration of FGF-21 induces energy expenditure, fat utilization and lipid excretion.